Radiofrequency ablation of thyroid nodules: “Good Clinical Practice Recommendations” for Austria

An interdisciplinary statement from the following professional associations: Austrian Thyroid Association (ÖSDG), Austrian Society for Nuclear Medicine and Molecular Imaging (OGNMB), Austrian Society for Endocrinology and Metabolism (ÖGES), Surgical Endocrinology Working Group (ACE) of the Austrian Surgical Society (OEGCH)
  • Harald DobnigEmail author
  • Wolfgang Zechmann
  • Michael Hermann
  • Michael Lehner
  • Dirk Heute
  • Siroos Mirzaei
  • Alois Gessl
  • Vinzenz Stepan
  • Günter Höfle
  • Philipp Riss
  • Andrea Simon
consensus paper


The present “Good Clinical Practice Recommendations” relate to radiofrequency ablation (RFA) training, execution, and quality control, as well as to pre- and postinterventional standards of care. They are aimed at all physicians who intend to learn to perform, or who are already conducting RFA interventions as well as at thyroid specialists providing pre- and postoperative care to RFA patients in Austria. Adoption of these recommendations is strongly encouraged by the afore-listed professional associations.

All RFA interventionists who adhere to these standards shall be listed on a homepage linked to these professional associations entitled “RFA centers in compliance with the GCP recommendations of the ÖSDG/OGNMB/ÖGES/OEGCH-ACE.” This will ensure harmonization of RFA training and quality control in the performance of the treatment in Austria.


Thermoablation RFA Statement GCP Monopolar Bipolar 


Conflict of interest

H. Dobnig, W. Zechmann, M. Hermann, M. Lehner, D. Heute, S. Mirzaei, A. Gessl, V. Stepan, G. Höfle, P. Riss, and A. Simon declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


  1. 1.
    Kim YS, Rhim H, Tae K, et al. Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid. 2006;16:361–7.CrossRefGoogle Scholar
  2. 2.
    Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18:1244–50.CrossRefGoogle Scholar
  3. 3.
    Baek JH, Kim YS, Lee D, et al. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol. 2010;194:1137–42.CrossRefGoogle Scholar
  4. 4.
    Sung JY, Baek JH, Kim KS, et al. Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology. 2013;269:293–300.CrossRefGoogle Scholar
  5. 5.
    Dobrinja C, Bernardi S, Fabris B, et al. Surgical and pathological changes after radiofrequency ablation of thyroid nodules. Int J Endocrinol. 2015; Scholar
  6. 6.
    Che Y, Jin S, Shi C, et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. AJNR Am J Neuroradiol. 2015;36:1321–5.CrossRefGoogle Scholar
  7. 7.
    Deandrea M, Sung JY, Limone P, et al. Efficacy and safety of radiofrequency ablation versus observation for nonfunctioning benign thyroid nodules: a randomized controlled international collaborative trial. Thyroid. 2015;25:890–6.CrossRefGoogle Scholar
  8. 8.
    Valcavi R, Tsamatropoulos P. Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign thyroid nodules: a 2-year follow-up study in 40 patients. Endocr Pract. 2015;21:887–96.CrossRefGoogle Scholar
  9. 9.
    Cesareo R, Pasqualini V, Simeoni C, et al. Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules. J Clin Endocrinol Metab. 2015;100:460–6.CrossRefGoogle Scholar
  10. 10.
    Dobnig H, Amrein K. Monopolar radiofrequency ablation of thyroid nodules: a prospective Austrian single-center study. Thyroid. 2018;28:472–80.CrossRefGoogle Scholar
  11. 11.
    Chen F, Tian G, Kong D, et al. Radiofrequency ablation for treatment of benign thyroid nodules: a PRISMA-compliant systematic review and meta-analysis of outcomes. Medicine. 2016; Scholar
  12. 12.
    Jung SL, Baek JH, Lee JH, et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study. Korean J Radiol. 2018;19:167–74.CrossRefGoogle Scholar
  13. 13.
    Ha EJ, Baek JH, Kim KW, et al. Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab. 2015;100:1903–11.CrossRefGoogle Scholar
  14. 14.
    Li XL, Xu HX, Lu F, et al. Treatment efficacy and safety of ultrasound-guided percutaneous bipolar radiofrequency ablation for benign thyroid nodules. Br J Radiol. 2016; Scholar
  15. 15.
    Kohlhase KD, Korkusuz Y, Groner D, et al. Bipolar radiofrequency ablation of benign thyroid nodules using a multiple overlapping shot technique in a 3-month follow-up. Int J Hyperthermia. 2016;32:511–6.CrossRefGoogle Scholar
  16. 16.
    Korkusuz Y, Mader A, Groner D, et al. Comparison of mono- and bipolar radiofrequency ablation in benign thyroid disease. World J Surg. 2017;41:2530–7.CrossRefGoogle Scholar
  17. 17.
    Barile A, Quarchioni S, Bruno F, et al. Interventional radiology of the thyroid gland: critical review and state of the art. Gland Surg. 2018;7:132–46.CrossRefGoogle Scholar
  18. 18.
    Gharib H, Hegedus L, Pacella CM, et al. Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab. 2013;98:3949–57.CrossRefGoogle Scholar
  19. 19.
    Na DG, Lee JH, Jung SL, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012;13:117–25.CrossRefGoogle Scholar
  20. 20.
    Kim JH, Baek JH, Lim HK, et al. 2017 thyroid radiofrequency ablation guideline: Korean society of thyroid radiology. Korean J Radiol. 2018;19:632–55.CrossRefGoogle Scholar
  21. 21.
    Garberoglio R, Aliberti C, Appetecchia M, et al. Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement. J Ultrasound. 2015;18:423–30.CrossRefGoogle Scholar
  22. 22.
    Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules—2016 update. Endocr Pract. 2016;22:622–39.CrossRefGoogle Scholar
  23. 23.
    Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26:1581–7.CrossRefGoogle Scholar
  24. 24.
    P. Mikosch, H. J. Gallowitsch, E. Kresnik, J. Jester, F.G. Würtz, K. Kerschbaumer, O. Unterweger, H.P. Dinges, P. Lind, (2000) Value of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules in an endemic goitre area. European Journal of Nuclear Medicine 27 (1):62-69CrossRefGoogle Scholar
  25. 25.
    Wang JF, Wu T, Hu KP, et al. Complications following radiofrequency ablation of benign thyroid nodules: A systematic review. Chin Med J 2017;130:1361-70.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2019

Authors and Affiliations

  • Harald Dobnig
    • 1
    • 12
    • 14
    Email author
  • Wolfgang Zechmann
    • 2
    • 12
    • 13
    • 14
  • Michael Hermann
    • 3
    • 12
    • 15
  • Michael Lehner
    • 4
    • 12
    • 13
  • Dirk Heute
    • 5
    • 12
    • 13
  • Siroos Mirzaei
    • 6
    • 12
    • 13
  • Alois Gessl
    • 7
    • 12
    • 14
  • Vinzenz Stepan
    • 8
    • 14
  • Günter Höfle
    • 9
    • 14
  • Philipp Riss
    • 10
    • 14
    • 15
  • Andrea Simon
    • 11
    • 15
  1. 1.Schilddrüsen Endokrinologie Osteoporose Institut DobnigGrazAustria
  2. 2.BirgitzAustria
  3. 3.Department of SurgeryHospital RudolfstiftungViennaAustria
  4. 4.Thyroid and Osteoporosis Practice Dr. Michael LehnerLinz and WelsAustria
  5. 5.Institute for Thyroid Diagnostics and Nuclear MedicineTelfsAustria
  6. 6.Institute for Nuclear Medicine with PET CenterWilhelminenspitalViennaAustria
  7. 7.Department of Medicine III, Division of Endocrinology and MetabolismMedical University of ViennaViennaAustria
  8. 8.Department of Internal MedicineHospital ElisabethinenGrazAustria
  9. 9.Department of Internal MedicineHospital HohenemsHohenemsAustria
  10. 10.Endocrine Surgery, Department of SurgeryMedical University of ViennaViennaAustria
  11. 11.Endocrine Surgery, Department of SurgeryMedical University of GrazGrazAustria
  12. 12.Austrian Thyroid Association (ÖSDG)ViennaAustria
  13. 13.Austrian Society for Nuclear Medicine and Molecular Imaging (OGNMB)ViennaAustria
  14. 14.Austrian Society for Endocrinology and Metabolism (ÖGES)ViennaAustria
  15. 15.Surgical Endocrinology Working Group (ACE)Austrian Surgical Society (OEGCH)ViennaAustria

Personalised recommendations